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ABSTRACT 
Objective: To investigate the anti-diabetic activity of combined ethanolic extracts (1:1mixture) of dry leaves of Syzygium cumini and Psidium 
guajava belonging to the family Myrtaceae as well as to compare the anti-diabetic activity of these plants by in vitro methods. 
Methods: In vitro glucose uptake assay was performed on cultured L6 cell lines (rat myoblast cell line) and estimated the glucose uptake using high 
sensitivity glucose oxidase kit. In vitro alpha amylase inhibitory assay was performed on porcine alpha amylase and the absorbance was measured 
at 540 nm using a microplate reader. Acarbose was used as the standard in both the methods. 
Results: At a concentration of 100µg/ml the percentage glucose uptake by the combined ethanolic extract (1:1 mixture) of Syzygium cumini and 
Psidium guajava leaves was 43.95 while for acarbose the corresponding value was 51.71. At 100 μg/ml the percentage of glucose uptake by 
Syzygium cumini and Psidium guajava was 27.62 and 22.17 respectively. The percentage inhibition of alpha amylase by the combined ethanolic 
extract (1:1 mixture) of Syzygium cumini and Psidium guajava leaves at a concentration of 1000 µg/ml was 36.51 and it was 29.26 for Syzygium 
cumini and 23.43 for Psidium guajava. For acarbose the percentage inhibition of alpha amylase was 73.82 at the concentration of 1000 µg/ml. 
Conclusion: The combined extract of the leaves of the plants selected was found to be more effective than individual plant extracts against diabetes. 
The percentage glucose uptake of the combined extract was found to be closer to that of the standard drug acarbose. On comparison of two plants 
Syzygium cumini was found to be more active against diabetes than Psidium guajava. As the 1:1 mixture of the ethanolic extract is found to be more 
active, the combination of the two plants can be used to formulate drugs for treating diabetes.  
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Syzgium cumini (Synonym: Eugenia jambolan Linn.) family 
Myrtaceae is a very large evergreen tropical tree [fig. 1]. The 
different parts of this plants have been used for a wide variety of 
ailments including cough, diabetes, dysentery, inflammation, 
pharyngitis, dermopathies, constipation, leucorrhoea and ringworm 
[1-3]. Psidium guajava L. known as Guava is a medicinal plant 
belonging to the family Myrtaceae [fig. 2]. Traditionally it is used for 
anorexia, cholera, diarrhoea, digestive problems, dysentery, gastric 
insufficiency, inflamed mucous membranes, laryngitis, skin 
problems, sore throat, ulcers, aches, bacterial infections, boils, bowel 
disorders, bronchitis, cold, colic, convulsions, cough, dyspepsia, 
oedema and epilepsy. Psidium guajava leaf extract is a potential 
reducing agent with biomedical applications [4, 5]. 
Diabetes mellitus (DM) which is one of the public health issues is a 
metabolic disorder characterized by the presence of chronic 
hyperglycaemia accompanied by an impairment of carbohydrate, 
lipid and protein metabolism that can lead to premature death. 
According to International Diabetes Federation report by 2030 
almost around 552 million will have DM. The 1997 American 
diabetic association’s recommendations for diagnosis of DM focus 
on fasting plasma glucose (FPG) while WHO focuses on oral 
glucose tolerance test [6-8]. In 2014, 422 million adults were 
living with diabetes compared to 108 million in 1980 across the 
world. Diabetes caused 1.5 million deaths in 2012. An additional 
2.2 million deaths were caused by higher than optimal blood 
glucose by increasing the risks of cardiovascular and other 
diseases [9]. 
Insulin dependent diabetes mellitus (TYPE 1 DM) known as “juvenile 
diabetes" occurs due to failure of pancreas to secrete enough insulin 
and is characterized by beta cell destruction caused by an 
autoimmune process; leading to absolute insulin deficiency. Type 1 
DM is characterized by the presence of anti–glutamic acid 
decarboxylase or insulin antibodies which identify the autoimmune 
processes that lead to beta cell destruction. Non-insulin dependent 
diabetes mellitus (Type 11 DM) known as adult onset diabetes 
begins with insulin resistance in which cells fail to respond to insulin 
properly. Lack of exercise and obesity may lead to this condition. 
Type 11 DM comprises 80% to 90% of all cases of DM. Diabetes 
which is triggered by pregnancy is called gestational diabetes as 
pregnancy may lead to insulin resistance. Around 10% of women 
with gestational diabetes may develop type II diabetes later [10]. 
Diabetes due to genetic defects of beta cell function or with defects 
of insulin action, diseases of the exocrine pancreas such as 
pancreatitis or cystic fibrosis, dysfunction associated with other 
endocrinopathies (e. g. acromegaly); and with pancreatic 
dysfunction caused by drugs, chemicals or infections are grouped 
together as monogenic or other specific type diabetes [11]. 
According to world ethno botanical information reports almost 800 
plants possess anti diabetic potential. Hypoglycaemic agents from 
natural products are gaining more importance due to their lower 
side effects. The use of phytochemicals may delay the development 
of diabetic complications and may regulate the metabolic 
abnormalities by different mechanisms. Several plants can be used 
as potential sources of new drugs to complement existing oral 
hypoglycaemic agents [12-14]. 
The aim of the present study was to compare the anti-diabetic 
activity of ethanolic extract of Syzygium cumini and Psidium guajava 
leaves and to investigate the anti-diabetic activity of the combined 
extract of both the plants. This study was designed with an objective 
to perform the in vitro glucose uptake assay on cultured L6 cell lines 
and alpha amylase inhibitory assay of the plants under study 
individually and as a combination of ethanolic leaf extracts of both 
Syzygium cumini and Psidium guajava. 
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Fig. 1: A. Syzygium cumini tree, B. Syzygium cumini leaves 
Source of fig.: Photographs of the tree and leaves were taken from 
Idukki District of Kerala. 
 
 
Fig. 2: A. Psidium guajava tree, B. Psidium guajava leaves 
Source of fig.: Photographs of the tree and leaves were taken from 
Idukki District of Kerala. 
 
MATERIALS AND METHODS 
Chemicals and reagents 
L6 cell line (rat myoblast cell line) was purchased from NCCS Pune 
and Dulbecco’s modified eagle’s media (DMEM) from Sigma Aldrich, 
USA. All other chemicals were procured either from Sigma, Ranbaxy 
fine Chemicals, New Delhi, Hi Media Mumbai or NICE chemicals Ltd, 
Cochin, Kerala, India. 
Collection and authentication of plant material  
The leaves of both plants were collected from the hilly regions of Idukki 
District, which is a densely forested mountainous region in the south 
Indian state of Kerala and were authenticated by Dr. Sr. Tessy Joseph, 
Professor, Department of Botany, Nirmala College, Muvattupuzha. 
Voucher specimen was deposited in the herbarium of Nirmala college, 
Muvattupuzha, Kerala, India with a Voucher no: NCBD 3812. 
Preparation of extracts 
The mature leaves of both Psidium guajava and Syzygium cumini were 
shade dried separately powdered in grinder to get coarse powder for 
extraction. 250 g of the Syzygium cumini leaf powder was extracted in 
ethanol (2.5 l) in a Soxhlet apparatus and concentrated to yield the crude 
ethanol extract of Syzygium cumini SC EL. Similarly 250 g of the crude 
powder of Psidium guajava leaf was extracted in ethanol (2.5 l) and 
concentrated to yield the crude ethanol extract of Psidium guajava PG EL. 
The extracts were concentrated using vacuum evaporator. 
In vitro glucose uptake assay on cultured L6 cell lines 
The L6 cell line (rat myoblast cell) was maintained in Dulbecco’s 
modified eagles media supplemented with 10% foetal bovine serum 
(FBS). The cells were grown to confluency at 37 °C in 5 % CO2 in a 
humidified atmosphere in a CO2 incubator (NBS, Eppendorf, 
Germany). The cells were trypsinized with 500 µl of 0.025% trypsin 
in phosphate buffered saline (PBS)/0.5 mmol ethylene diamine tetra 
acetic acid (EDTA) solution (In vitrogen) for 2 min and passaged to T 
flasks in complete aseptic conditions. The cells were subcultured to a 
24 well plate. The cells were kept in DMEM without glucose for 24 h 
after attaining 80% confluency. To the grown cells added the 
extracts at a final concentration of 25 µg, 50 µg and 100 µg from a 
stock of 1 mg/ml and incubated in DMEM containing 300 mmol 
glucose for 24 h. An untreated control with high glucose was also 
maintained. The cells were isolated after incubation by spinning at 
6000 rpm for 10 min. The supernatant was discarded and added 200 
µl of cell lysis buffer (1MTrisHcl, 0.25M EDTA, 2M Nacl, 0.5% 
Triton). The mixture was incubated for 30 min at 4 °C and estimated 
the glucose uptake using high sensitivity glucose oxidase kit. All 
experiments were repeated in triplicates and mean average was 
used for calculations [15]. 
%	Glucose	uptake	  OD	of	test  OD	of	Control  OD	of	test  100 
In vitro alpha amylase inhibitory assay 
Different concentrations of samples (125μg/ml–1000μg/ml) were 
prepared from a stock concentration of 10 mg/ml and made up to 
1000 µl using 25 mmol phosphate buffer pH 6.9, containing 25 µl of 
porcine α amylase at a concentration of 0.5 mg/ml. The mixtures 
were incubated at 25 °C for 10 min. After pre incubation, 25 µl of 
0.5% starch solution in 25 mmol phosphate buffer pH 6.9 was added 
to the mixtures. The reaction mixtures were then incubated at 25 °c 
for 10 min. The reaction was stopped with 50 µl of 96 mmol 3, 5-
dinitro salicylic acid colour reagent. The micro plate was then 
incubated in a boiling water bath for 5 min and cooled to room 
temperature. Absorbance was measured at 540 nm using a 
microplate reader (Erba, Lisascan) [16]. 
CALCULATION 
% inhibition =  
 
Table 1: Effect of different concentrations of acarbose and the plant extracts on glucose uptake by the L6 cell lines 
S. No. Sample Concentration Absorbance Percentage glucose uptake (µg/ml) Bias 
1 Control - 0.1702±0.96 -  
2 Acarbose 25 0.2900±1.02 41.31  
 (Standard) 50 0.3189±1.34 46.63  
  100 0.3525±1.22 51.71  
3 Ethanolic extract of  25 0.2007±0.98 15.23 0.0893 
 Syzygium cumini 50 0.2148±1.65 20.79 0.1041 
 (SC EL) 100 0.2351±0.94 27.62 0.1174 
4 Ethanolic extract of  25 0.1836±1.79 7.3 0.1064 
 Psidium guajava 50 0.2035±0.98 16.4 0.1154 
 (PG EL) 100 0.2186±0.86 22.17 0.1339 
5 1:1 mixture of  25 0.2273±1.54 25.15 0.0627 
 SC EL and PG EL 50 0.2654±1.12 35.87 0.0535 
  100 0.3036±1.42 43.95 0.0489 
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RESULTS AND DISCUSSION 
The 1:1 mixture of ethanolic extract of Psidium guajava and 
Syzygium cumini leaves was found to possess good glucose uptake 
activity than either of the individual extracts. The percentage of 
glucose uptake by ethanolic extract of the leaves of Psidium guajava, 
Syzygium cumini, 1:1 mixture of both and acarbose, the standard 
drug are tabulated in table 1. The result showed that the combined 
extract has good activity comparable with that of acarbose. Results 
are expressed as mean±SD (n=3). The glucose uptake assay on L6 rat 
myoblast cells was performed at three concentrations 25, 50 and 100 
μg/ml. The results revealed that the combined ethanolic extract (1:1 
mixture) of Psidium guajava and Syzygium cumini at 100 μg/ml 
increased the glucose uptake by 43.95% compared to control. The 
percentage increase in glucose uptake by acarbose the standard 
drug at 100 μg/ml was 51.71. At 100 μg/ml the percentage increase 
in glucose uptake by Syzygium cumini and Psidium guajava was 
27.62 and 22.17 respectively on comparison with control. All the 
extracts showed a dose dependant increase in glucose uptake by L6 
rat myoblast cells. 
Table 1: The percentage increase of glucose uptake of standard drug 
acarbose, ethanolic extract of Syzygium cumini (SC EL), Psidium 
guajava (PG EL) and the 1:1mixture of ethanolic extracts of Syzygium 
cumini and Psidium guajava (SC EL+PG EL) at 25 μg/ml, 50μg/ml 
and 100μg/ml with respect to control. Results are expressed as 
mean±SD (n=3) and statistical significance was evaluated by one-
way analysis of variance (ANOVA). The percentage of glucose uptake 
by SC EL, PG EL and the 1:1 mixture of SC EL+PG EL was compared 
with standard acarbose and the P values are 0.827, 0.856 and 0.359 
respectively. The mixture SCEL+PG EL has least difference from the 
standard acarbose when compared with others. The bias of 
absorbance values calculated with respect to the standard drug 
acarbose is least for 1:1 mixture SC EL+PG EL when compared to the 
other two test groups.  
The In vitro α-amylase inhibitory studies demonstrated that the 
combined ethanolic extract (1:1 mixture) of Psidium guajava and 
Syzygium cumini has more inhibitory activity on α-amylase than 
individual ethanolic extracts of Psidium guajava and Syzygium 
cumini. The extracts were tested and compared with the standard 
drug acarbose for α-amylase inhibitory activity at four 
concentrations 125, 250, 500 and 1000 μg/ml. The percentage 
inhibition of α-amylase activity by ethanolic extracts of the leaves of 
Psidium guajava, Syzygium cumini, 1:1 mixture of both and acarbose 
are tabulated in table 2. Results are expressed as mean±SD (n=3). All 
the extracts showed a dose dependant increase in the inhibitory 
activity. At a concentration of 1000μg/ml the combined ethanolic 
extract (1:1 mixture) of Psidium guajava and Syzygium cumini 
showed an inhibition of 36.51 % while it was 29.26% for Syzygium 
cumini and 23.43 % for Psidium guajava. For standard drug acarbose 
the percentage inhibition of alpha amylase at 1000μg/ml was 73.82. 
 
Table 2: Alpha amylase inhibitory activity of different concentrations of acarbose and the plant extracts on porcine alpha amylase 
S. No. Sample  Concentration (µg/ml) Absorbance at 540 nm Percentage of inhibition Bias 
 Acarbose 125 0.0543±0.86 55.85  
1 (Standard) 250 0.0539±0.57 58.61  
  500 0.0492±0.64 60.00  
  1000 0.0322±0.75 73.82  
  Control 0.1230±0.45 -  
2 Ethanolic extract of  125 0.2113±0.67 12.54 0.1570 
 Syzygium cumini 250 0.1941±0.34 19.66 0.1402 
 (SC EL) 500 0.1805±0.53 25.29 0.1313 
  1000 0.1709±0.66 29.26 0.1387 
  Control 0.2416±0.47 - 0.1186 
3 Ethanolic extract of  125 0.2132±0.66 11.75 0.1589 
 Psidium guajava 250 0.2016±0.57 16.56 0.1477 
 (PG EL) 500 0.1977±0.76 18.17 0.1485 
  1000 0.1850±0.87 23.43 0.1528 
  Control 0.2416±0.42 - 0.1186 
4 1:1 mixture of  125 0.1905±0.43 21.15 0.1362 
 SC EL and PG EL 250 0.1767±0.42 26.86 0.1228 
  500 0.1739±0.75 28.02 0.1247 
  1000 0.1534±0.68 36.51 0.1212 
  Control 0.2416±0.74 - 0.1186 
 
Table 2: Alpha amylase inhibitory activity of standard drug acarbose, 
ethanolic extract of Syzygium cumini (SC EL), Psidium guajava (PG 
EL) and the 1:1mixture of ethanolic extracts of Syzygium cumini and 
Psidium guajava (SC EL+PG EL) at 125 μg/ml, 250μg/ml, 500μg/ml 
and 1000μg/ml with respect to control. Results are expressed as 
mean±SD (n=3) and statistical significance was evaluated by one-
way analysis of variance (ANOVA). The percentage inhibition of 
alpha amylase by SC EL, PG EL and SCEL+PG EL was compared with 
standard acarbose and the P values are 0.937, 0.968 and 0.908 
respectively. The mixture SCEL+PG EL has least difference from the 
standard acarbose, when compared with others. The bias of 
absorbance values calculated with respect to the standard drug 
acarbose is least for 1:1 mixture SC EL+PG EL when compared to the 
other two test groups.  
Insulin resistance, which is the reduced response of target tissues 
such as the skeletal muscle, liver, and adipocytes to insulin, plays a 
major role in the pathogenesis of Type II Diabetes. Skeletal muscle is 
the predominant site of insulin-mediated glucose uptake in the 
postprandial state. Normal glucose homeostasis depends on a well-
balanced interaction between tissue (muscle, liver and fat) 
sensitivity to insulin and insulin secretion [17]. The present study 
showed that the ability of the combined ethanolic extract of 
Syzygium cumini and Psidium guajava to increase the percentage 
glucose uptake is comparable to that of the standard drug acarbose 
showing its ability to reduce post prandial blood sugar level. 
Type II Diabetes mellitus can be treated by reducing post prandial 
hyperglycaemia. The intestinal digestive enzyme alpha amylase is a 
carbohydrate hydrolyzing enzyme. Alpha amylase inhibitors prevent 
break down of polysaccharide in to mono and disaccharide. Thus 
alpha amylase inhibitors can prevent the postprandial hyperglycaemia 
by preventing glucose release from starch and delaying carbohydrate 
metabolism [18]. This research demonstrated the better anti diabetic 
potential of the 1:1 mixture of ethanolic extract of Syzygium cumini and 
Psidium guajava leaves by its ability to inhibit alpha amylase more 
effectively than either of the individual plant extracts of Syzygium 
cumini and Psidium guajava leaves. 
The results of the glucose uptake assay and alpha amylase inhibitory 
assay demonstrated that even though the individual ethanolic plant 
extracts of Syzygium cumini and Psidium guajava could increase the 
glucose uptake and inhibit the alpha amylase activity, the combined 
ethanolic extracts of both the plants increased the glucose uptake 
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and inhibited the alpha amylase more efficiently than individual 
plants. So the combined ethanolic extract (1:1 mixture) of Psidium 
guajava and Syzygium cumini can act as a better anti diabetic agent. 
Plants containing various phytochemicals exhibit additive and 
synergistic interaction in exerting anti diabetic properties which is a 
beneficial effect to formulate more potent anti-diabetic drugs in 
combination [19]. 
CONCLUSION  
In the present study the ethanolic extract of leaves of Psidium 
guajava, Syzygium cumini and 1:1 mixture of ethanolic extract of 
both Psidium guajava and Syzygium cumini leaves increased the 
glucose uptake by L6 rat myoblast cells and exhibited alpha amylase 
inhibition properties. This indicates the ability of the plants under 
study to act as anti-diabetic agents. Among the three extracts studied 
the combined extract of Psidium guajava and Syzygium cumini was 
found to be more active than either of the plants alone. Further 
studies are recommended to find the mechanism behind this 
synergistic or additive effect. This study also suggests that the active 
compounds isolated from these plants can be used as lead 
compound for designing potent anti-diabetic drugs. Based on the 
future investigations the plants can be utilised as the components of 
a polyherbal formulation for treating diabetes. 
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